


Ask a doctor about a prescription for QUETIAPINE QUALIGEN FARMA 150 mg PROLONGED-RELEASE TABLETS
PATIENT INFORMATION LEAFLET
Quetiapine Qualigen Farma 150 mg prolonged-release tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack and other information
Quetiapine Qualigen Farma contains a substance called quetiapine. It belongs to a group of medicines called antipsychotics. Quetiapine Qualigen Farma can be used to treat several diseases, such as:
When Quetiapine Qualigen Farma prolonged-release tablets are used to treat major depressive episodes in major depressive disorder, they will be taken in addition to another medication that is being used to treat this disease.
Your doctor may continue to prescribe Quetiapine Qualigen Farma even when you are feeling better.
Do not take Quetiapine Qualigen Farma if any of the above applies to you. If you are in doubt, consult your doctor or pharmacist before taking Quetiapine Qualigen Farma.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Quetiapine Qualigen Farma if:
If you are an elderly person with Parkinson's disease/parkinsonism.
If you have or have had a disorder in which you stop breathing for short periods during normal nighttime sleep (called "sleep apnea") and are taking medications that slow down normal brain activity ("depressants").
The use of these medications with quetiapine may cause serotonin syndrome, a potentially life-threatening condition (see Other medicines and Quetiapine Qualigen Farma).
Tell your doctor immediately if, after taking Quetiapine Qualigen Farma, you experience any of the following:
These disorders may be caused by this type of medication.
Tell your doctor as soon as possible if you have:
Thoughts of suicide and worsening of your depression
If you are depressed, you may sometimes think of harming or killing yourself. This may increase when you first start treatment, as all these medications take time to work, usually around two weeks but sometimes more. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of suicidal thoughts and/or suicidal behavior in young adults under 25 years of age with depression.
If at any time you think of harming or killing yourself, contact your doctor or go to a hospital immediately. It may help to tell a relative or close friend that you are depressed and ask them to read this leaflet. You can ask them to tell you if they think your depression is getting worse, or if they are worried about changes in your behavior.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should regularly check your weight.
Children and adolescents
Quetiapine Qualigen Farma should not be used in children and adolescents under 18 years of age.
Other medicines and Quetiapine Qualigen Farma
Tell your doctor if you are taking, have recently taken, or might take any other medicines.
Do not take Quetiapine Qualigen Farma if you are using any of the following medicines:
Tell your doctor if you are using any of the following medicines:
Medicines (called "anticholinergics") that affect the functioning of nerve cells and are used to treat certain diseases.
Antidepressants. These medicines may interact with quetiapine, and you may experience symptoms such as involuntary muscle contractions and rhythmic movements of the muscles, including the muscles that control eye movement, agitation, hallucinations, coma, excessive sweating, tremors, exaggerated reflexes, increased muscle tension, and body temperature above 38°C (serotonin syndrome). Contact your doctor if you experience these symptoms.
Before stopping any of your medicines, consult your doctor first.
Taking Quetiapine Qualigen Farma with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
You should not take Quetiapine Qualigen Farma during pregnancy, unless your doctor has advised you to do so. You should not use Quetiapine Qualigen Farma if you are breastfeeding.
The following symptoms, which may represent a withdrawal syndrome, may appear in newborns of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and using machines
These tablets may make you feel drowsy. Do not drive or operate tools or machines until you know how the tablets affect you.
Effect on drug detection tests in urine
If you are undergoing a urine drug detection test, taking quetiapine may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when some analysis methods are used, even if you are not taking methadone or TCAs. If this happens, a more specific test can be performed.
Quetiapine Qualigen Farma contains lactose
If your doctor has told you that you have an intolerance to some sugars, consult them before taking the medicine.
Patients with liver problems
If you have liver problems, your doctor may change your dose.
Elderly patients
If you are an elderly patient, your doctor may change your dose.
Use in children and adolescents
Quetiapine Qualigen Farma should not be used in children and adolescents under 18 years of age.
If you take more Quetiapine Qualigen Farma than you should
If you take more Quetiapine Qualigen Farma than your doctor has prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring the Quetiapine Qualigen Farma tablets with you. You can also call the Toxicology Information Service, Tel: 915620420, indicating the medicine and the amount taken.
If you forget to take Quetiapine Qualigen Farma
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the forgotten tablet.
If you stop taking Quetiapine Qualigen Farma
If you stop taking Quetiapine Qualigen Farma abruptly, you may be unable to sleep (insomnia), or you may feel nauseous, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest gradually reducing the dose before stopping treatment.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Very Common Adverse Effects (may affect more than 1 in 10 people):
Common Adverse Effects (may affect up to 1 in 10 people):
o In both men and women, having swollen breasts and unexpected milk production.
o In women, not having menstrual periods or having irregular periods.
Uncommon Adverse Effects (may affect up to 1 in 100 people):
Rare Adverse Effects (may affect up to 1 in 1,000 people):
Very Rare Adverse Effects (may affect up to 1 in 10,000 people):
Unknown Frequency (cannot be estimated from available data):
Stroke
Heart muscle disorder (cardiomyopathy).
Heart muscle inflammation (myocarditis).
Blood vessel inflammation (vasculitis), often with a skin rash with small red or purple spots.
The class of medicines to which Quetiapina Qualigen belongs can cause heart rhythm problems that can be serious and, in severe cases, potentially fatal.
Some adverse effects are only observed when a blood test is performed. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreased number of certain types of blood cells, decreased number of red blood cells, increased creatine phosphokinase in the blood (a substance found in muscles), decreased sodium in the blood, and increased prolactin hormone in the blood. The increases in prolactin hormone could, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Adverse Effects in Children and Adolescents
The same adverse effects that can occur in adults can also occur in children and adolescents.
The following adverse effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very Common Adverse Effects (may affect more than 1 in 10 people):
Common Adverse Effects (may affect up to 1 in 10 people):
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Do not use this medicine after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions. Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
The active ingredient is quetiapine. The tablets contain 50 mg of quetiapine (as quetiapine fumarate).
The other ingredients are:
Core of the tablet: lactose, methacrylic acid - ethyl acrylate copolymer (1:1), crystalline maltose type A, magnesium stearate, and talc.
Coating of the tablet: Methacrylic acid - ethyl acrylate copolymer (1:1), type A, triethyl citrate.
Appearance of Quetiapina Qualigen Farma and Package Contents
The 50 mg prolonged-release tablets are white or almost white, round, biconvex, with "50" engraved on one side, 7.1 mm in diameter, and 3.2 mm in thickness.
They are presented in aluminum/PVC/PCTFE blisters in a cardboard box.
The package sizes are: 10, 30, 50, 60, 100, and 180 tablets.
Not all package sizes may be marketed.
Marketing Authorization Holder
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona
Manufacturer
Pharmathen International, S.A.
Industrial Park Sapes Rodopi Prefecture Block Nº 5
Rodopi 69300
Greece
or
Pharmathen, S.A.
Dervenakion 6
Pallini Attiki, 15351
Greece
or
neuraxpharm Arzneimittel GmbH
Elisabeth-Selbert-Str. 23
40764 Langenfeld
Germany
Date of the Last Revision of this Leaflet: June 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of QUETIAPINE QUALIGEN FARMA 150 mg PROLONGED-RELEASE TABLETS in November, 2025 is around 48.61 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for QUETIAPINE QUALIGEN FARMA 150 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.